Production of riboflavin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10633684
APP PUB NO 20110312025A1
SERIAL NO

13127618

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides an improved biotechnological production of riboflavin (also referred herein as vitamin B2) through modification in the operon containing the riboflavin biosynthetic genes (rib operon), in particular modifications of/in the leader sequences (rib leader) upstream of the corresponding riboflavin biosynthetic genes (rib operon). Furthermore, the present invention relates to genetically engineered microorganisms carrying said modified sequences, processes to generate said modified sequences/microorganisms and the use thereof for production of riboflavin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DSM IP ASSETS B VNETHERLANDS GELEEN LIMBURG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hans, Michael Schopfheim, DE 15 37
Hohmann, Hans-Peter Loerrach, DE 15 54
Laudert, Dietmar Schopfheim, DE 3 0
Lehmann, Martin Grenzach-Wyhlen, DE 120 833

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 28, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 28, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00